Syra Health (SYRA) director Form 3 reports no share ownership held

Rhea-AI Filing Summary

Syra Health Corp director Radhika Mereddy filed an initial insider ownership report on Form 3. This filing states that, as of the event date of 08/13/2025, she had no securities beneficially owned in Syra Health Corp. Both the non-derivative and derivative securities tables show no holdings, and the explanation of responses confirms that no securities are beneficially owned.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 01/13/2026 - 04:54 PM Learn about SEC filing dates

FAQ

What does the Syra Health (SYRA) Form 3 filed by Radhika Mereddy show?

Radhika Mereddy, a director of Syra Health Corp, filed a Form 3 stating that she has no securities beneficially owned in the company as of 08/13/2025.

What is Radhika Mereddy’s relationship to Syra Health Corp (SYRA)?

The filing identifies Radhika Mereddy as a director of Syra Health Corp and not a 10% owner or officer.

Does the Syra Health (SYRA) director own any shares according to this Form 3?

No. The Form 3 explicitly states in the explanation of responses that no securities are beneficially owned by the reporting person.

Are any derivative securities reported for the Syra Health (SYRA) director?

No. The section for derivative securities beneficially owned does not list any positions for Radhika Mereddy.

What is the event date related to this Syra Health (SYRA) Form 3?

The Form 3 lists 08/13/2025 as the date of event requiring statement for the reporting person.

Who signed the Syra Health (SYRA) Form 3 and when?

The Form 3 was signed by /s/ Radhika Mereddy and dated 01/13/2026.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mereddy Radhika

(Last) (First) (Middle)

C/O SYRA HEALTH CORP.

1119 KEYSTONE WAY N., #201

(Street)

CARMEL IN 46032

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/13/2025

3. Issuer Name and Ticker or Trading Symbol
Syra Health Corp [ SYRA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Radhika Mereddy	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.